Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

2022 NCI Career Development Program Selections

, by Justine E. Yu, Ph.D.

Postdoctoral fellows Burak Altintas, M.D., in the Clinical Genetics Branch, Brittany Lord, Ph.D., M.P.H., M.S., and Waruiru Mburu, Ph.D., M.P.H., in the Integrative Tumor Epidemiology Branch, Omonefe Omofuma, Ph.D., M.S., in the Metabolic Epidemiology Branch, and Elisa Pasqual, Ph.D., in the Radiation Epidemiology Branch were selected for the 2022 NCI Career Development Program (CDP). The program seeks to provide NCI postdoctoral trainees with the tools necessary to develop as leaders in independent academic research careers. CDP is an important part of NCI’s efforts to build and support the biomedical research workforce.

Collage of 5 people: Burak Altintas, Brittany Lord, Waruiru Mburu, Omonefe Omofuma, and Elisa Pasqual

Burak Altintas, Brittany Lord, Waruiru Mburu, Omonefe Omofuma, and Elisa Pasqual (2022)

< Older Post

Small Increases in Physical Activity Could Prevent Over 100,000 Deaths/Year

Newer Post >

Jonathan Hofmann Awarded Scientific Tenure by the NIH

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “2022 NCI Career Development Program Selections was originally published by the National Cancer Institute.”

Email